Arcadia Biosciences, Inc. (RKDA) Shareholders’ equity 2017–2025
Arcadia Biosciences, Inc. (RKDA) shareholders’ equity at each fiscal year-end, per SEC filings.
$4.1MFY2025 · since FY2017: $8.0M → $4.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.1M | -33.5% |
| FY2024 | $6.2M | -51.5% |
| FY2023 | $12.8M | -38.9% |
| FY2022 | $21.0M | -32.4% |
| FY2021 | $31.1M | +12.1% |
| FY2020 | $27.7M | +259.8% |
| FY2019 | $7.7M | -39.9% |
| FY2018 | $12.8M | +60.0% |
| FY2017 | $8.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice